Related references
Note: Only part of the references are listed.Modified natriuretic peptides and their potential roles in cancer treatment
Mengjiao Xu et al.
BIOMEDICAL JOURNAL (2022)
Identification of a Prognostic Signature Based on the Expression of Genes Related to the Insulin Pathway in Early Breast Cancer
Alessandra Gennari et al.
BREAST CARE (2021)
Infiltration of CD204-overexpressing Macrophages Contributes to the Progression of Stage II and III Colorectal Cancer
Yoichiro Tada et al.
ANTICANCER RESEARCH (2021)
Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme
Rebecca N. Adamek et al.
CHEMMEDCHEM (2021)
Targeting Insulin-Degrading Enzyme in Insulin Clearance
Malcolm A. Leissring et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Obesity, Type 2 Diabetes, and Cancer Risk
Tiffany Scully et al.
FRONTIERS IN ONCOLOGY (2021)
From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment
Yuval Nash et al.
FASEB JOURNAL (2021)
S-Nitrosylation in Tumor Microenvironment
Vandana Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Neuroendocrine Factors in Melanoma Pathogenesis
Cristian Scheau et al.
CANCERS (2021)
Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity
Bhargavi Ramaraju et al.
BIOCHEMISTRY (2021)
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Aldona Kasprzak
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Revising Endosomal Trafficking under Insulin Receptor Activation
Maria J. Iraburu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases
Luis Sousa et al.
JOURNAL OF PATHOLOGY (2021)
Insulin-Degrading Enzyme: Paradoxes and Possibilities
Malcolm A. Leissring
CELLS (2021)
Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice
Carlos M. Gonzalez-Casimiro et al.
CELLS (2021)
Targeting Adipokines in Obesity-Related Tumors
Xi Pu et al.
FRONTIERS IN ONCOLOGY (2021)
Drug Target Engagement Using Coupled Cellular Thermal Shift Assay-Acoustic Reverse-Phase Protein Array
Adrien Herledan et al.
SLAS DISCOVERY (2020)
Rethinking the Relationship between Insulin and Cancer
R. Vigneri et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Jan Korbecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Calcitonin gene-related peptide: A promising bridge between cancer development and cancer-associated pain in oral squamous cell carcinoma
Yu Zhang et al.
ONCOLOGY LETTERS (2020)
The Links between Parkinson's Disease and Cancer
Maria Ejma et al.
BIOMEDICINES (2020)
Autophagy-dependent secretion: mechanism, factors secreted, and disease implications
Jacob New et al.
AUTOPHAGY (2019)
A Practical Review of Proteasome Pharmacology
Tiffany A. Thibaudeau et al.
PHARMACOLOGICAL REVIEWS (2019)
Alzheimer's Disease and Cancer: When Two Monsters Cannot Be Together
Shohreh Majd et al.
FRONTIERS IN NEUROSCIENCE (2019)
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
Juan Pablo Maianti et al.
NATURE CHEMICAL BIOLOGY (2019)
Hepatic Insulin Clearance: Mechanism and Physiology
Sonia M. Najjar et al.
PHYSIOLOGY (2019)
Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin
Pooja Sharma et al.
CELLS (2019)
Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
Cristina M. Fernandez-Diaz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Amyloid β oligomers inhibit growth of human cancer cells
Bozena Pavliukeviciene et al.
PLOS ONE (2019)
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening
Florence Leroux et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
SIRT4 regulates PTEN stability through IDE in response to cellular stresses
Minghui Liu et al.
FASEB JOURNAL (2019)
Site directed mutagenesis of insulin-degrading enzyme allows singling out the molecular basis of peptidase versus E1-like activity: the role of metal ions
Francesco Bellia et al.
METALLOMICS (2019)
Inflammation and Cancer
Nitin Singh et al.
ANNALS OF AFRICAN MEDICINE (2019)
Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme
Lazaros Stefanidis et al.
BIOCHEMISTRY (2018)
The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S
Diego Sbardella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Ubiquitination: Friend and foe in cancer
Mohammed A. Mansour
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
The cell biology of systemic insulin function
Victoria L. Tokarz et al.
JOURNAL OF CELL BIOLOGY (2018)
Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display
Caitlin N. Suire et al.
PLOS ONE (2018)
Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways
Takashi Yagi et al.
Oncotarget (2018)
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
Zhening Zhang et al.
ELIFE (2018)
Stabilized β-Hairpin Peptide Inhibits Insulin Degrading Enzyme
Dan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Regulation of proteasome assembly and activity in health and disease
Adrien Rousseau et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice
Pablo Villa-Perez et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Insulin Receptor Isoforms in Cancer
Veronica Vella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies
Andreea Calinescu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Natriuretic Peptides: The Case of Prostate Cancer
Letizia Mezzasoma et al.
MOLECULES (2017)
Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes
Eun Suk Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis
Jian Cao et al.
ONCOTARGET (2017)
Interleukin-6 increases the expression and activity of insulin-degrading enzyme
Mirian A. Kurauti et al.
SCIENTIFIC REPORTS (2017)
The proteasome and proteasome inhibitors in multiple myeloma
Sara Gandolfi et al.
CANCER AND METASTASIS REVIEWS (2017)
Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
Grazia R. Tundo et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression
James T. Thackeray et al.
JCI INSIGHT (2017)
Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
Olga Pivovarova et al.
ANNALS OF MEDICINE (2016)
Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease
Sung Min Son et al.
AUTOPHAGY (2016)
Endoplasmic Reticulum Stress and the Hallmarks of Cancer
Hery Urra et al.
TRENDS IN CANCER (2016)
Modulation of insulin degrading enzyme activity and liver cell proliferation
Olga Pivovarova et al.
CELL CYCLE (2015)
The insulin degrading enzyme activates ubiquitin and promotes the formation of K48 and K63 diubiquitin
G. Grasso et al.
CHEMICAL COMMUNICATIONS (2015)
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme
Julie Charton et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides
Jheelam Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Structures of Human CCL18, CCL3, and CCLA Reveal Molecular Determinants for Quaternary Structures and Sensitivity to Insulin-Degrading Enzyme
Wenguang G. Liang et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
Michael M. Gottesman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution
Diego Sbardella et al.
PLOS ONE (2015)
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Rebecca Deprez-Poulain et al.
NATURE COMMUNICATIONS (2015)
Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner
Sandeep K. Sharma et al.
SCIENTIFIC REPORTS (2015)
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
Michael M. Gottesman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The insulin/IGF system in colorectal cancer development and resistance to therapy
Paolo Giovanni Vigneri et al.
FRONTIERS IN ONCOLOGY (2015)
Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells
Grazia R. Tundo et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2015)
The role of kinin receptors in cancer and therapeutic opportunities
Patricia L. N. da Costa et al.
CANCER LETTERS (2014)
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
Julie Charton et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
No Major Role for Insulin-Degrading Enzyme in Antigen Presentation by MHC Molecules
Slobodan Culina et al.
PLOS ONE (2014)
Class A scavenger receptor activation inhibits endoplasmic reticulum stress-induced autophagy in macrophage
Hanpeng Huang et al.
JOURNAL OF BIOMEDICAL RESEARCH (2014)
Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice
Justin W. Caravaggio et al.
CARDIOVASCULAR PATHOLOGY (2013)
Insulin-degrading Enzyme (IDE) A NOVEL HEAT SHOCK-LIKE PROTEIN
Grazia Raffaella Tundo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Macrophage Scavenger Receptor A Promotes Tumor Progression in Murine Models of Ovarian and Pancreatic Cancer
Claudine Neyen et al.
JOURNAL OF IMMUNOLOGY (2013)
Deletion of the Fission Yeast Homologue of Human Insulinase Reveals a TORC1-Dependent Pathway Mediating Resistance to Proteotoxic Stress
Clementine Beuzelin et al.
PLOS ONE (2013)
Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic Aβ Peptide Aggregates
Matias B. de Tullio et al.
PLOS ONE (2013)
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
Lauren A. McCord et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment
Takamitsu Sasaki et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Anion Activation Site of Insulin-degrading Enzyme
Nicholas Noinaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides
Yun-Gon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration
Juliany S. B. Cesar Vieira et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling Response
Luis A. Ralat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ubiquitin Is a Novel Substrate for Human Insulin-Degrading Enzyme
Luis A. Ralat et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: Relevance to Alzheimer's prevention
Liqin Zhao et al.
NEUROBIOLOGY OF AGING (2011)
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
Samer O. Abdul-Hay et al.
PLOS ONE (2011)
Identification of the Allosteric Regulatory Site of Insulysin
Nicholas Noinaj et al.
PLOS ONE (2011)
Intracellular insulin in human tumors: examples and implications
Razvan T. Radulescu
DIABETOLOGY & METABOLIC SYNDROME (2011)
Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: Implications for cell proliferation control
Razvan T. Radulescu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme
Min Ren et al.
EMBO JOURNAL (2010)
Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-beta Degrading Protease
Ayelen Bulloj et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Molecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading Enzyme
Qing Guo et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Insulin-Degrading Enzyme Binds to the Nonglycosylated Precursor of Varicella-Zoster Virus gE Protein Found in the Endoplasmic Reticulum
J. E. Carpenter et al.
JOURNAL OF VIROLOGY (2010)
Production of an antigenic peptide by insulin-degrading enzyme
Nicolas Parmentier et al.
NATURE IMMUNOLOGY (2010)
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
Malcolm A. Leissring et al.
PLOS ONE (2010)
Insulin Degrading Enzyme Induces a Conformational Change in Varicella-Zoster Virus gE, and Enhances Virus Infectivity and Stability
Qingxue Li et al.
PLOS ONE (2010)
Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells
O. Pivovarova et al.
DIABETOLOGIA (2009)
Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme
Ying-Hao Chou et al.
FASEB JOURNAL (2009)
Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation
Luis A. Ralat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme
Marika Manolopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Somatostatin: A Novel Substrate and a Modulator of Insulin-Degrading Enzyme Activity
Chiara Ciaccio et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Complex formation between metabolic enzymes in tumor cells: Unfolding the MDR1-IDE paradigm
Razvan T. Radulescu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Ji Zhao et al.
MOLECULAR NEURODEGENERATION (2009)
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
Christelle Cabrol et al.
PLOS ONE (2009)
Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme
Enrico Malito et al.
BIOCHEMISTRY (2008)
How the binding and degrading capabilities of insulin degrading enzyme are-affected by ubiquitin
Giuseppe Grasso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines
Gregor Weirich et al.
BIOLOGICAL CHEMISTRY (2008)
Amyloid β-degrading cryptidases:: insulin degrading enzyme, presequence peptidase, and neprilysin
E. Malito et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Antitumor effects of somatostatin
Stephane Pyronnet et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme A biological perspective
Matias B. de Tullio et al.
PRION (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Regulation of protein degradation by insulin-degrading enzyme: Analysis by small interfering RNA-mediated gene silencing
Janet Fawcett et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE
Hookang Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IGF1R signalling and its inhibition
J. Riedemann et al.
ENDOCRINE-RELATED CANCER (2006)
Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread
Qingxue Li et al.
CELL (2006)
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Yuequan Shen et al.
NATURE (2006)
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid β-protein
W Farris et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis
K Nosho et al.
CLINICAL CANCER RESEARCH (2004)
Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria
MA Leissring et al.
BIOCHEMICAL JOURNAL (2004)
Non-covalent interaction of ubiquitin with insulin-degrading enzyme
T Saric et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo
BC Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Degradation of amylin by insulin-degrading enzyme
RG Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins
M Morita et al.
CELL STRUCTURE AND FUNCTION (2000)
Share Paper
